##common.pageHeaderLogo.altText##

Special article

Vol. 156 No. 2 (2026)

Improving psychosocial and digital care pathways for Duchenne muscular dystrophy: insights from the Duchenne Switzerland Conference 2025

Cite this as:
Swiss Med Wkly. 2026;156:5132
Published
12.02.2026

Summary

Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease, affecting approximately 1 in 3,500 to 5,000 live male births worldwide. Despite medical advances, families continue to face considerable challenges in navigating fragmented health and social care systems, coping with long-term uncertainty, and accessing timely psychosocial and digital support.

This viewpoint summarises key themes, identifies knowledge transfer strategies, and proposes future directions for optimising DMD care in Switzerland and internationally. It reflects the growing recognition that successful care for rare diseases such as DMD must centre families and follow a holistic approach that combines excellent clinical care with digital innovation and psychosocial support frameworks.

Our conclusions are drawn from the Duchenne Switzerland Conference 2025, held on 26 September at the Swiss Paraplegic Centre in Nottwil, Switzerland, a unique forum for interdisciplinary exchange between families, clinicians, therapists, researchers, and patient organisations involved in the care and support of individuals with DMD. With over 120 participants and a fully multilingual setup, the conference highlighted current care challenges, psychosocial needs across the DMD care continuum, and emerging digital health solutions.

The programme included keynote lectures and parallel sessions covering topics such as digital platforms and patient journey tools, assistive technologies, participation and empowerment, mental health, care management, and community-based care. Evidence from international and national research projects, including data from the Care-NMD-CH project, underscored regional disparities and systemic gaps in service provision. The role of coordinated care networks such as Myosuisse and Swiss-Reg-NMD was also discussed in the context of citizen science and participatory research and care approaches.

Workshops and presentations showcased examples of inclusive technologies and participatory health communication, including AI-assisted translation and digital tools to enhance daily autonomy and engagement for individuals with DMD. Sessions on mental health and resilience highlighted the ongoing emotional and psychological strain on families, emphasising the need for sustainable psychosocial interventions as part of integrated care.

References

  1. 1. Gruebner O, Elayan S, Sykora M, Wolf M, von Rhein M, Fadda M. Pediatric Neuromuscular Diseases and Psychosocial Wellbeing: Why We Also Need to Invest in Digital Platforms [Internet]. Int J Public Health. 2024 Jun;69:1607460. Available from: https://www.ssph-journal.org/articles/10.3389/ijph.2024.1607460/full 10.3389/ijph.2024.1607460
  2. 2. Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al.; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management [Internet]. Lancet Neurol. 2018 Mar;17(3):251–67. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1474442218300243 doi: https://doi.org/10.1016/S1474-4422(18)30024-3
  3. 3. Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Colvin MK, et al.; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan [Internet]. Lancet Neurol. 2018 May;17(5):445–55. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1474442218300267 doi: https://doi.org/10.1016/S1474-4422(18)30026-7
  4. 4. Straub V, Balabanov P, Bushby K, Ensini M, Goemans N, De Luca A, et al. Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy [Internet]. Lancet Neurol. 2016 Jul;15(8):882–90. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1474442216300357 doi: https://doi.org/10.1016/S1474-4422(16)30035-7
  5. 5. Bever A, Audhya I, Szabo SM, Mickle A, Feeny D, Malone D, et al. “You Take This Day by Day, Come What May”: A Qualitative Study of the Psychosocial Impacts of Living with Duchenne Muscular Dystrophy [Internet]. Adv Ther. 2024 Jun;41(6):2460–76. Available from: https://link.springer.com/10.1007/s12325-024-02867-0 10.1007/s12325-024-02867-0
  6. 6. Balidemaj A, Parsamanesh P, Vysochyn M. Exploring the Dynamics of Caring for a Child With a Terminal Illness of Duchenne Muscular Dystrophy (DMD) and Its Copious Components on the Caregivers. Cureus [Internet]. 2023 May 28; https://www.cureus.com/articles/149610-exploring-the-dynamics-of-caring-for-a-child-with-a-terminal-illness-of-duchenne-muscular-dystrophy-dmd-and-its-copious-components-on-the-caregivers
  7. 7. Hawken T, Turner-Cobb J, Barnett J. Coping and adjustment in caregivers: A systematic review [Internet]. Health Psychol Open. 2018 Nov;5(2):2055102918810659. Available from: https://journals.sagepub.com/doi/10.1177/2055102918810659 10.1177/2055102918810659
  8. 8. Resch JA, Benz MR, Elliott TR. Evaluating a dynamic process model of wellbeing for parents of children with disabilities: a multi-method analysis [Internet]. Rehabil Psychol. 2012 Feb;57(1):61–72. Available from: https://doi.apa.org/doi/10.1037/a0027155 10.1037/a0027155
  9. 9. Yanamadala S, Morrison D, Curtin C, McDonald K, Hernandez-Boussard T. Electronic Health Records and Quality of Care: An Observational Study Modeling Impact on Mortality, Readmissions, and Complications [Internet]. Medicine (Baltimore). 2016 May;95(19):e3332. Available from: https://journals.lww.com/00005792-201605100-00010 doi: https://doi.org/10.1097/MD.0000000000003332
  10. 10. Waldboth V, Schuler C, Willmann R, Petry H, Weber M, Grädel Messerli B, et al. A participatory mixed-method study protocol to develop, implement and evaluate a Care Management model for patients with Neuromuscular Diseases (Care-NMD-CH Study) (Preprint) [Internet]. 2025. http://preprints.jmir.org/preprint/82833